-
Arsenal on the brink of Premier League title after nervy Burnley win
-
Oil rises, global stocks mixed as markets track Iran developments
-
World Cup winner Pavard confirms Marseille exit
-
Trump says holding off on new Iran attack
-
Cuba warns of 'bloodbath' if US attacks; Washington adds sanctions
-
Trump says delaying Iran attack at request of Gulf leaders
-
Cuba warns of 'bloodbath' if US attacks and Washington issues sanctions
-
After mayor's murder, Mexico battles to bring peace
-
Trump admin creates $1.7 bln fund to compensate allies prosecuted under Biden
-
Pelicans name Mosley as coach, two weeks after Magic firing
-
Hyderabad qualify for IPL play-offs along with Gujarat
-
'Girl in the River Main' identified 25 years on, father arrested
-
Musk loses blockbuster OpenAI suit as jury says too late
-
SNC Scandic Coin and Biconomy: Regulated real-world assets meet global trading infrastructure
-
Judge allows gun as evidence in Mangione healthcare exec murder trial
-
First attack on Arab nuclear site sends warning to Gulf, US
-
Oil rises, bond yields weigh on stocks
-
Hormuz tanker traffic edges higher after wartime low
-
Andalusia setback highlights weakness of Spain's ruling Socialists
-
India's Adani to pay $275 mn settlement to US over alleged Iran sanctions violations
-
Middle East tourism pain is Europe's gain
-
UK Labour leadership hopeful reopens Brexit debate
-
PSG's Dembele has treatment for leg issue before Champions League final
-
Spurs must play with 'courage' to seal safety: De Zerbi
-
Hantavirus-hit cruise ship ends deadly voyage
-
Champagne start in Reims for 2028 Tour de France
-
Dogs allowed on new Brigitte Bardot beach in glitzy Cannes
-
Oil prices dip on report of US sanctions relief for Iran during talks
-
Croatia names Modric-led World Cup squad
-
Iran World Cup squad lands in south Turkey for training
-
Mushfiqur ton leaves Pakistan needing record run chase to beat Bangladesh
-
Transport protests hit Kenya over rising fuel prices
-
Ex-Google exec takes reins at under-fire BBC
-
France unveils architects to transform Louvre
-
'Mesmeric' movie on secret lives of Nigeria's rich wows Cannes
-
Ex-Google man takes reins at under-fire BBC
-
Swatch blames shopping centres for 'problems' with star product launch
-
Carvajal to leave Real Madrid at end of season
-
Stocks drop, oil climbs after fresh Trump warning to Iran
-
Blockbuster 'Hope' shows S.Korea's growing movie muscle
-
Twins wow Cannes with 'mesmeric' tale of Nigeria's rich
-
New Ebola outbreak in DR Congo: What we know
-
Iran Nobel winner discharged from hospital: supporters
-
Spanish court orders 55 mn euro tax refund to Shakira
-
Ryanair flags Iran war uncertainty as annual profit jumps
-
Hearts have bright future despite Scottish title pain: McInnes
-
Fernandes 'proud' to match Premier League assists record
-
Germany set to miss 2030 climate goal: experts
-
G7 finance chiefs meet to seek common stance on unstable ground
-
Freedom of speech 'not an absolute right', Hong Kong trial of Tiananmen activists hears
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
M.AlAhmad--SF-PST